3 Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks With a Strong Future Roadmap: Concord Biotech, India Glycols and Emami
- October 19, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Concord Biotech Rs 1,339.00, P/E 51.00. India Glycols Rs 331.95, P/E 7.58. Emami Rs 376.15, P/E 21.39. Closing prices of 14 Oct 2026.
Quick Answer
Fermentation ingredient maker, ethanol chemical firm and personal care brand stocks with the clearest long-term roadmaps today include Concord Biotech in fermentation-based active ingredients, including immunosuppressants and anti-infectives, India Glycols in glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Emami in personal care and wellness brands such as Navratna, Zandu and BoroPlus. P/E stands at 51.00 for Concord Biotech (industry 37.59), 7.58 for India Glycols (industry 54.53) and 21.39 for Emami (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.
Fermentation ingredient maker, ethanol chemical firm and personal care brand stocks give investors exposure to drug ingredients, green chemicals and personal care. Volumes, pricing and margins decide how much of that demand turns into profit.
This list covers three fermentation ingredient maker, ethanol chemical firm and personal care brand stocks: Concord Biotech for fermentation-based active ingredients, including immunosuppressants and anti-infectives, India Glycols for glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Emami for personal care and wellness brands such as Navratna, Zandu and BoroPlus. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks?
Fermentation ingredient maker, ethanol chemical firm and personal care brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.
Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three fermentation ingredient maker, ethanol chemical firm and personal care brand stocks as of the 14 Oct 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| Concord Biotech | 1,339.00 | 13,913 | 51.00 | 37.59 | 12.94% | 0.00 |
| India Glycols | 331.95 | 2,397 | 7.58 | 54.53 | 9.98% | 0.58 |
| Emami | 376.15 | 16,041 | 21.39 | 34.85 | 26.51% | 0.06 |
Among healthcare, chemicals and consumer stocks, Concord Biotech trades at a premium to the industry P/E, while India Glycols and Emami trade at a discount.
Why Do Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks Have a Strong Roadmap in India?
Fermentation ingredient maker, ethanol chemical firm and personal care brand stocks have a strong roadmap in India because ingredient demand, ethanol blending and household brands keep adding volumes for these firms. Three drivers stand out.
- Drug ingredients: Drugmakers buy fermentation-based actives.
- Green chemicals: Ethanol and bio-based chemicals find buyers.
- Personal care: Families buy balms, creams and wellness products.
Concord Biotech: Fermentation Ingredients Drive the Pipeline
Concord Biotech’s roadmap rests on fermentation-based active ingredients, including immunosuppressants and anti-infectives, with regulated market exports supporting revenue.
Revenue grew from Rs 736.35 crore in FY22 to Rs 1,107.25 crore in FY26, a 50.4% rise. FY26 net profit was Rs 259.23 crore. In Q1 FY27, revenue grew 24.2% to Rs 270.32 crore, and net profit rose 31.0% to Rs 57.70 crore. Operating margin was 39.81% in FY26.
Debt to equity is 0.00 and return on equity is 12.94%. FY26 operating cash flow was Rs 266.88 crore against capital expenditure of Rs 95.15 crore. Concord Biotech paid a dividend of Rs 7.55 per share for FY26, a yield of 0.57%. At a P/E of 51.00 against an industry P/E of 37.59, the stock trades above its industry multiple.
What to watch: The P/E of 51.00 sits above the industry P/E of 37.59, so earnings delivery matters for the valuation.
India Glycols: Green Chemicals and Ethanol Build the Next Leg
India Glycols’ roadmap rests on glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock, with ethanol blending and chemical demand supporting volumes.
Revenue grew from Rs 2,889.84 crore in FY22 to Rs 4,216.34 crore in FY26, a 45.9% rise, and FY26 revenue was 11.5% higher than FY25. FY26 net profit rose 26.8% to Rs 292.76 crore. In Q1 FY27, revenue grew 19.3% to Rs 2,988.82 crore, and net profit rose 32.2% to Rs 96.83 crore. Operating margin was 7.12% in FY26.
Debt to equity is 0.58 and return on equity is 9.98%. FY26 operating cash flow was Rs 769.16 crore against capital expenditure of Rs 823.48 crore. India Glycols paid a dividend of Rs 7.5 per share for FY26, a yield of 2.10%. At a P/E of 7.58 against an industry P/E of 54.53, the stock trades below its industry multiple.
What to watch: The P/E of 7.58 against an industry P/E of 54.53 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
Emami: Personal Care and Wellness Brands Anchor the Roadmap
Emami’s roadmap rests on personal care and wellness brands such as Navratna, Zandu and BoroPlus, with a seasonal product mix and strong brands supporting sales.
Revenue grew from Rs 3,287.28 crore in FY22 to Rs 3,864.63 crore in FY26, a 17.6% rise. FY26 net profit was Rs 775.25 crore. In Q1 FY27, revenue grew 14.3% to Rs 1,057.71 crore. Operating margin was 27.37% in FY26.
Debt to equity is 0.06 and return on equity is 26.51%. FY26 operating cash flow was Rs 800.53 crore against capital expenditure of Rs 43.32 crore. Emami paid a dividend of Rs 10 per share for FY26, a yield of 2.72%. At a P/E of 21.39 against an industry P/E of 34.85, the stock trades below its industry multiple.
What to watch: The P/E of 21.39 against an industry P/E of 34.85 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
Best Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks in India: Concord Biotech vs India Glycols vs Emami on Key Financials
Among the best fermentation ingredient maker, ethanol chemical firm and personal care brand stocks in India, Concord Biotech leads on FY26 operating margin and Q1 FY27 revenue growth; India Glycols leads on the lowest P/E; Emami leads on return on equity and dividend yield. The table puts the numbers side by side.
| Metric | Concord Biotech | India Glycols | Emami |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 1,107.25 | 4,216.34 | 3,864.63 |
| FY26 net profit (Rs Cr) | 259.23 | 292.76 | 775.25 |
| FY26 operating profit margin | 39.81% | 7.12% | 27.37% |
| Q1 FY27 revenue growth (YoY) | 24.2% | 19.3% | 14.3% |
| Return on equity | 12.94% | 9.98% | 26.51% |
| P/E ratio | 51.00 | 7.58 | 21.39 |
| Debt to equity | 0.00 | 0.58 | 0.06 |
| Dividend yield | 0.57% | 2.10% | 2.72% |
| FY26 operating cash flow (Rs Cr) | 266.88 | 769.16 | 800.53 |
Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.
How to Evaluate Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen fermentation ingredient maker, ethanol chemical firm and personal care brand stocks and shortlist fermentation ingredient maker, ethanol chemical firm and personal care brand stocks to buy.
- Compare each stock’s P/E with its industry P/E, which differs by company here.
- Check revenue growth, operating margin and cash flow together.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read operating cash flow against capital expenditure to see how growth is funded.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Risks to Consider Before Investing in Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks
- Consumer demand: Spending patterns can shift sales between quarters.
- Input costs: Changes in raw material prices can affect margins.
- Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.
Download the Univest iOS App or Univest Android App to track Concord Biotech, India Glycols and Emami live.
Final Take: Which Stock Has the Strongest Roadmap?
These three healthcare, chemicals and consumer stocks cover an ingredient maker, a chemical firm and a personal care brand. Concord Biotech leads on FY26 operating margin and Q1 FY27 revenue growth; India Glycols leads on the lowest P/E; Emami leads on return on equity and dividend yield.
Across fermentation ingredient maker, ethanol chemical firm and personal care brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the fermentation ingredient maker, ethanol chemical firm and personal care brand stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Fermentation Ingredient Maker, Ethanol Chemical Firm and Personal Care Brand Stocks
Which are the best fermentation ingredient maker, ethanol chemical firm and personal care brand stocks in India with a strong roadmap?
Ans. Concord Biotech, India Glycols and Emami stand out for their roadmaps in an ingredient maker, a chemical firm and a personal care brand. Return on equity ranges from 9.98% to 26.51%.
Is Concord Biotech a good stock to buy now?
Ans. Concord Biotech has a debt to equity ratio of 0.00, a return on equity of 12.94% and a P/E of 51.00 against an industry P/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of Concord Biotech, India Glycols and Emami?
Ans. The P/E ratio is 51.00 for Concord Biotech (industry 37.59), 7.58 for India Glycols (industry 54.53) and 21.39 for Emami (industry 34.85). Only Concord Biotech trades at or above the industry multiple.
Which of these fermentation ingredient maker, ethanol chemical firm and personal care brand stocks has the highest return on equity?
Ans. Emami has the highest return on equity at 26.51%, followed by Concord Biotech at 12.94% and India Glycols at 9.98%.
What are the risks of investing in fermentation ingredient maker, ethanol chemical firm and personal care brand stocks?
Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.
How did Concord Biotech, India Glycols and Emami perform in Q1 FY27?
Ans. Concord Biotech reported revenue of Rs 270.32 crore, up 24.2% year on year, and net profit rose 31.0% to Rs 57.70 crore. India Glycols reported revenue of Rs 2,988.82 crore, up 19.3% year on year, and net profit rose 32.2% to Rs 96.83 crore. Emami reported revenue of Rs 1,057.71 crore, up 14.3% year on year.
Do fermentation ingredient maker, ethanol chemical firm and personal care brand stocks pay dividends?
Ans. Yes, all three companies pay dividends. The dividend yield is 0.57% for Concord Biotech, 2.10% for India Glycols and 2.72% for Emami, based on dividends declared for FY26.
How can I invest in fermentation ingredient maker, ethanol chemical firm and personal care brand stocks in India?
Ans. You can buy fermentation ingredient maker, ethanol chemical firm and personal care brand stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.
